Fluid-loss control pills comprising breakers that comprise orthoesters and/or poly(orthoesters) and methods of use

Abstract

Provided herein are methods and compositions for generating acids for use downhole, for example, to break fluid-loss control pills. The delayed-release acid breakers of the present invention comprise orthoesters and/or poly(orthoesters).

1 . A method comprising: 
 providing a fluid-loss control pill that comprises an aqueous base fluid and a gelling agent, and a delayed-release acid breaker that comprises an orthoester and/or a poly(orthoester);    introducing the fluid-loss control pill and the delayed-release acid breaker into a subterranean formation;    allowing the delayed-release acid breaker to generate an acid after a delay period; and    allowing the fluid-loss control pill to break.    
   
   
       2 . The method of  claim 1  wherein the orthoester has the general formula RC(OR′)(OR″)(OR′″), wherein R′, R″, and R′″ are not hydrogen, and R′, R″, and R′″ may or may not be the same group.  
   
   
       3 . The method of  claim 2  wherein R′, R″, or R′″ comprise a heteroatom.  
   
   
       4 . The method of  claim 1  wherein the gelling agent comprises a polymer selected from the group consisting of: a natural polymer; a synthetic polymer; xanthan; a xanthan derivative; guar; a guar derivative; cellulose; a cellulose derivative; carboxymethylhydroxyethyl cellulose; hydroxyethyl cellulose; a graft copolymer of hydroxyethyl or hydroxypropyl cellulose prepared by a redox reaction with vinyl phosphonic acid monomers or polymers; polyacrylate; polymethacrylate; polyamylamide; polyvinyl alcohol; polyvinylpyrolidone; a depolymerized gelling agent; derivatives thereof; and combinations thereof.  
   
   
       5 . The method of  claim 1  wherein the orthoester is an orthoacetate; an orthoformate; an orthopropionate; or an orthoester of a polyfunctional alcohol.  
   
   
       6 . The method of  claim 1  wherein the poly(orthoester) is a poly(orthoacetate); a poly(orthoformate); or a poly(orthopropionate).  
   
   
       7 . The method of  claim 1  wherein the gelling agent comprises a crosslinked gelling agent that has been crosslinked in a crosslinking reaction that comprises a crosslinking agent.  
   
   
       8 . The method of  claim 7  wherein the crosslinking agent is a crosslinking agent that comprises a polyvalent metal ion; a Lewis base; a Bronsted-Lowrey base; boron; titanium; or zirconium.  
   
   
       9 . The method of  claim 1  wherein the fluid-loss control pill comprises an additive selected from the group consisting of: propylene glycol; a gel stabilizer; a clay fixer; a bridging particulate; a surfactant; a corrosion inhibitor; a biocide; a pH control additive; an oxidizer; an encapsulated breaker; and a weighting agent.  
   
   
       10 . A fluid-loss control pill base gel that comprises a delayed-acid release breaker that comprises an orthoester and/or a poly(orthoester).  
   
   
       11 . The delayed-release acid breaker of  claim 10  wherein the orthoester or the poly(orthoester) is in a solution form, an emulsion form, a solid form, or a gel form.  
   
   
       12 . The method of  claim 10  wherein the orthoester has the general formula RC(OR′)(OR″)(OR′″), wherein R′, R″, and R′″ are not hydrogen, and R′, R″, and R′″ may or may not be the same group.  
   
   
       13 . The method of  claim 10  wherein the orthoester is an orthoacetate; an orthoformate; an orthopropionate; or an orthoester of a polyfunctional alcohol.  
   
   
       14 . The method of  claim 10  wherein the poly(orthoester) is one of the following group: a poly(orthoacetate); a poly(orthoformate); or a poly(orthopropionate).  
   
   
       15 . A method comprising: 
 providing a delayed-release acid breaker that comprises an orthoester and/or a poly(orthoester), and a fluid-loss control pill base gel having a pH below about 8;    forming a first emulsion that comprises the delayed-release acid breaker and water;    adding the first emulsion to the fluid-loss control pill base gel to form a second emulsion having a continuous phase and a discontinuous phase, the discontinuous phase comprising the delayed-release acid breaker and the continuous phase comprising the fluid-loss control pill base gel; and    introducing the second emulsion into a subterranean formation.    
   
   
       16 . The method of  claim 15  wherein the fluid-loss control pill base gel comprises at least one of the following group: propylene glycol; a gel stabilizer; a clay fixer; a bridging particulate; a surfactant; a corrosion inhibitor; a biocide; a pH control additive; an oxidizer; an encapsulated breaker; a weighting agent; fresh water; salt water; 
 a brine; a zinc chloride brine; an ammonium chloride brine; seawater; a sodium chloride brine; a potassium chloride brine; a calcium chloride brine; a sodium bromide brine; a calcium bromide brine; and a zinc bromide brine.    
   
   
       17 . The method of  claim 15  wherein the orthoester has the general formula RC(OR′)(OR″)(OR′″), wherein R′, R″, and R′″ are not hydrogen, and R′, R″, and R′″ may or may not be the same group.  
   
   
       18 . The method of  claim 15  wherein the orthoester is an orthoacetate; an orthoformate; an orthopropionate; or an orthoester of a polyfunctional alcohol.  
   
   
       19 . The method of  claim 15  wherein the poly(orthoester) is a poly(orthoacetate); a poly(orthoformate); or a poly(orthopropionate).  
   
   
       20 . The method of  claim 15  wherein the gelling agent is a natural polymer; a synthetic polymer; xanthan; a xanthan derivative; guar; a guar derivative; cellulose; a cellulose derivative; carboxymethylhydroxyethyl cellulose; hydroxyethyl cellulose; a graft copolymer of hydroxyethyl or hydroxypropyl cellulose prepared by a redox reaction with vinyl phosphonic acid monomers or polymers; polyacrylate; polymethacrylate; polyamylamide; polyvinyl alcohol; polyvinylpyrolidone; a depolymerized gelling agent; derivatives thereof; or combinations thereof.